Twnk Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TWNK (Twinkle Mitochondrial DNA Helicase) encodes a mitochondrial DNA helicase essential for mitochondrial DNA (mtDNA) replication. It is the replicative helicase that unwinds mtDNA at the replication fork. Mutations in TWNK cause mitochondrial DNA depletion syndromes and progressive external ophthalmoplegia (PEO).
| Attribute |
Value |
| Gene Symbol |
TWNK |
| Gene Name |
Twinkle Mitochondrial DNA Helicase |
| Chromosomal Location |
10q24.31 |
| Ensembl ID |
ENSG00000107815 |
| OMIM ID |
604367 |
| UniProt ID |
Q96QR1 |
| Also Known As |
PEO1, TWNK |
TWNK is a 684-amino acid protein with ATP-dependent 3'-5' DNA helicase activity. It forms hexamers that function as the replicative helicase for mtDNA.
- Mitochondrial DNA helicase activity
- ATP-dependent DNA unwinding
- Initiation of mtDNA replication
- mtDNA maintenance
- Replication fork progression
TWNK is expressed ubiquitously with high expression in tissues with high mitochondrial energy requirements.
- Autosomal dominant TWNK mutations cause PEO
- Multiple mtDNA deletions accumulate in muscle
- Onset typically in adulthood
- Progressive external ophthalmoplegia, ptosis, myopathy
- TWNK variants may modify PD risk
- mtDNA replication defects in PD brains
- Mitochondrial dysfunction in dopaminergic neurons
- Infantile-onset spinocerebellar ataxia (IOSCA)
- Perrault syndrome (hearing loss with gonadal dysgenesis)
- Mitochondrial DNA depletion syndrome
- No current disease-modifying treatments
- Supportive care for mitochondrial disease
- Experimental approaches: gene therapy, nucleotide supplementation
- Twnk knockout mice show embryonic lethality
- Conditional knockout causes mitochondrial dysfunction
The study of Twnk Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Spelbrink JN, et al. (2001). Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle. EMBO Journal, 20(5): 1146-1155.
- Tyynismaa H, et al. (2012). Twinkle and mitochondrial disease. Biochimica et Biophysica Acta, 1819(9-10): 850-857.
- Hashimoto M, et al. (2018). TWNK mutations and mitochondrial disease. Neurology, 91(10): 446-453.
- Goffart S, et al. (2021). Twinkle helicase mechanisms. Journal of Biological Chemistry, 296: 100447.
- Suomalainen A, et al. (2020). Mitochondrial DNA replication disorders. Nature Reviews Disease Primers, 6(1): 51.
¶ Structure and Mechanism
¶ Protein Domain Architecture
TWNK (Twinkle) contains several key structural features:
- N-terminal targeting sequence: Mitochondrial localization signal
- Hexamerization domain: Forms functional hexameric helicase
- RecA-like helicase core: ATP-dependent DNA unwinding
- C-terminal regulatory domain: Interaction with other mtDNA replication proteins
TWNK functions as an ATP-dependent helicase:
- Binds to mtDNA at the replication origin
- Hydrolyzes ATP to unwind double-stranded DNA
- Moves along the DNA in 3'-5' direction
- Separates template strands for polymerase engagement
The helicase works in concert with:
- POLG: Mitochondrial DNA polymerase gamma
- SSBP1: Single-stranded binding protein
- TFAM: Mitochondrial transcription factor A
- MGME1: Mitochondrial genome maintenance exonuclease 1
TWNK mutations lead to accumulation of multiple mtDNA deletions:
- Defective replication stalling causes template switching
- Incomplete replication products accumulate
- Deleted mtDNA molecules replicate preferentially
- Eventually dominant negative effect
Why certain tissues are affected:
- High energy demand (muscle, brain, heart)
- Post-mitotic cells cannot dilute damaged mtDNA
- Ocular muscles have high mitochondrial density
Core symptoms:
- External ophthalmoplegia: Reduced eye movements
- Ptosis: Drooping eyelids
- Myopathy: Muscle weakness, especially proximal
- Exercise intolerance: Fatigue with minimal exertion
- Severe multisystem disease
- Ataxia, hypotonia, hearing loss
- Usually fatal in early adulthood
- Sensorineural hearing loss (both ears)
- Gonadal dysgenesis in females
- Neurological features in some patients
- Targeted panel for mitochondrial disorders
- Whole exome sequencing
- mtDNA deletion analysis
- Serum FGF-21 and GDF-15 elevated
- CSF lactate sometimes increased
- Muscle biopsy shows ragged-red fibers
- Supportive care only
- Physical therapy for myopathy
- Cochlear implants for hearing loss
- Ophthalmological interventions for ptosis
- Allotopic gene expression: Deliver functional TWNK via AAV
- Nucleotide supplementation: Precursor loading
- Mitochondrial replacement therapy: IVF approach
- Part of mitochondrial DNA replisome
- Helicase activity
- Primer synthesis for mtDNA
- Progressive external ophthalmoplegia (PEO)
- Kearns-Sayre syndrome
- mtDNA depletion syndromes
- Altered mtDNA in AD/PD
- Therapeutic targeting potential